IP Verse

Hutter competitive analysis

Explore the latest publications and patents granted to Hutter, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Hutter against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP4255973	Nanocellular Expanded Polymer Beads, Method Of Manufacture And Uses	CELLMAT SL	Jul 29, 2025
EP3661562	Method Of Conjugation Of Cys-Mabs	AMGEN	Jun 30, 2025
EP3889181	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jan 24, 2025
EP2872837	Refrigerator	REMIS GESELLSCHAFT FR ENTWICKLUNG UND VERTRIEB VON TECHNISCHEN ELEMENTEN KLN	Jan 9, 2025
EP3630946	Cell Culture Methods	UCB BIOPHARMA	Dec 20, 2024
EP3818078	Methods Of Producing Recombinant Proteins	BRISTOL MYERS SQUIBB	Nov 28, 2024
EP3515465	Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor	REGENERON PHARMACEUTICALS	Nov 7, 2024
EP3973987	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Oct 10, 2024
EP3283059	Method For Producing Rna Compositions	CUREVAC	Oct 3, 2024
EP3589661	Adjuvant Treatment Of Her2-Positive Breast Cancer	F HOFFMANN LA ROCHE	Aug 1, 2024

Discover the latest PTAB cases involving Hutter, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Hutter with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB	26	-	-	-	Highly Aggressive
GENENTECH	-	86	-	65	Non-Active
IMMUNOCORE	-	9	-	-	Non-Active
REGENERON PHARMACEUTICALS	38	93	9	30	Balanced